Overall, this study establishes an aptamer-targeted nucleic acid nanoplatform that integrates antimicrobial delivery, biofilm disruption, and host immunomodulation, offering a promising therapeutic strategy for multidrug-resistant S. aureus skin infections.
Jiang et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: